SBFM Q1 2021 Earnings — Sunshine Biopharma, Inc. Revenue & Financial Results | Market Cap Arena

SBFMSunshine Biopharma, Inc.

$6M

Q1 2021 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$40,058+260.8% YoY

Gross Profit

$21,53853.8% margin

Operating Income

-$1M-3185.4% margin

Net Income

-$6M-15440.1% margin

EPS (Diluted)

$-5640.00

QoQ Revenue Growth

+43.0%

Cash Flow

Operating Cash Flow

-$297,355

Free Cash Flow

-$297,355

Stock-Based Comp.

$918,000

Balance Sheet

Total Assets

$2M

Total Liabilities

$3M

Stockholders' Equity

-$1M

Cash & Equivalents

$2M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$40,058	$11,102	+260.8%
Gross Profit	$21,538	$7,219	+198.4%
Operating Income	-$1M	-$37,699	-3284.7%
Net Income	-$6M	-$94,259	-6461.7%